Get the Stockscreener App
860.20
0.97%
-8.80
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corp stock is traded at $860.20, with a volume of 468.85K.
It is down -0.97% in the last 24 hours and up +2.27% over the past month.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$869.00
Open:
$859.49
24h Volume:
468.85K
Relative Volume:
0.44
Market Cap:
$100.30B
Revenue:
$403.43B
Net Income/Loss:
$5.10B
P/E Ratio:
22.36
EPS:
38.4657
Net Cash Flow:
$5.41B
1W Performance:
-2.20%
1M Performance:
+2.27%
6M Performance:
-9.08%
1Y Performance:
+27.86%
1-Day Range:
$855.93
$879.34
1-Week Range:
$852.99
$902.05
52-Week Range:
$667.50
$999.00
Mckesson Corp Stock (MCK) Company Profile
Name
Mckesson Corp
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corp
|
860.30 | 101.32B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
312.46 | 59.89B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
234.88 | 54.69B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
90.11 | 10.00B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.20 | 1.09B | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corp Stock (MCK) Latest News
McKesson director Bradley Lerman sells $268,589 in shares By Investing.com - Investing.com Australia
McKesson director Bradley Lerman sells $268,589 in shares - Investing.com
Summit Global Investments Invests $1.16 Million in McKesson Corporation $MCK - MarketBeat
Mckesson Stock Price Forecast. Should You Buy MCK? - StockInvest.us
BIP Wealth LLC Invests $1.75 Million in McKesson Corporation $MCK - MarketBeat
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
MCK|Mckesson Corp|Price:869.000|Chg%:+11.760 - TradingKey
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Insight Wealth Strategies LLC Trims Holdings in McKesson Corporation $MCK - MarketBeat
McKesson Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
BARLOW WEALTH PARTNERS, LLC's McKesson Corp(MCK) Holding History - GuruFocus
McKesson Corporation (MCK.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Continuum Advisory, LLC's McKesson Corp(MCK) Holding History - GuruFocus
Wedge Capital Management L L P NC Has $29.42 Million Position in McKesson Corporation $MCK - MarketBeat
McKesson Corporation (MCK) latest stock news and headlines - uk.finance.yahoo.com
What Does McKesson’s (NYSE:MCK) $105B Quarter Mean for S&P 500 Investors? - Kalkine Media
McKesson Corp (MCK) Director Bradley Lerman Sells 301 Shares, Re - GuruFocus
McKesson (NYSE:MCK) Director Sells $268,591.33 in Stock - MarketBeat
McKesson (NYSE:MCK) Given New $933.00 Price Target at Wells Fargo & Company - MarketBeat
Wells Fargo raises McKesson stock price target on earnings outlook By Investing.com - Investing.com Australia
Wells Fargo raises McKesson stock price target on earnings outlook - Investing.com
Handelsbanken Fonder AB Cuts Stock Holdings in McKesson Corporation $MCK - MarketBeat
E. Ohman J or Asset Management AB Boosts Stock Position in McKesson Corporation $MCK - MarketBeat
McKesson Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
MCKESSON CORP SEC Filing (Aug 10, 2026) - Stock Titan
MCKESSON CORP : JP MORGAN RAISES TARGET PRICE TO $1042 FROM $1015 - Bitget
6,734 Shares in McKesson Corporation $MCK Bought by Deane Retirement Strategies Inc. - MarketBeat
Mckesson Corp (MCK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
McKesson Corporation $MCK Shares Acquired by Hennion & Walsh Asset Management Inc. - MarketBeat
McKesson Corporation $MCK Shares Sold by Assenagon Asset Management S.A. - MarketBeat
McKesson Q1 Earnings Call Highlights - MarketBeat
McKesson: Solid Q1 Earnings And Management Execution (Rating Upgrade) - Seeking Alpha
How Higher Sales, Lower EPS And New Guidance At McKesson (MCK) Has Changed Its Investment Story - Yahoo Finance
$1000 Invested In McKesson 5 Years Ago Would Be Worth This Much Today - Benzinga
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
PensionDanmark Pensionsforsikringsaktieselskab Grows Stake in McKesson Corporation $MCK - MarketBeat
LLY5600583 Bond Profile — Key Metrics - TradingView
Mckesson Corp Stock (MCK) Moved Down by 3.44% on Aug 6: What Signal Does It Send? - TradingKey
Eastern Bank Sells 17,975 Shares of McKesson Corporation $MCK - MarketBeat
Canandaigua National Bank & Trust Co. Invests $1.56 Million in McKesson Corporation $MCK - MarketBeat
McKesson Kicks Off Fiscal 2027 With Solid Results Underpinned by Specialty and Margin Strength - Morningstar
McKesson’s IPO-bound spin-off to keep local HQ, rebrand as Wellverse - Richmond BizSense
McKesson Corp (MCK) (Q1 2027) Earnings Call Highlights: Robust R - GuruFocus
McKesson: Fiscal Q1 Earnings Snapshot - Austin American-Statesman
Earnings call transcript: McKesson tops Q1 2026 estimates and lifts outlook - Investing.com
McKesson Q1 FY2027 slides: 20% EPS growth, raised outlook - Investing.com
McKesson Q1 FY2027 slides: 20% EPS growth drives guidance raise - Investing.com
A Look at McKesson Corp (MCK) After 5.6% Gain -- GF Value $798.0 - GuruFocus
Is McKesson Corp (MCK) Overvalued After Q1 Earnings Miss? EPS $5 - GuruFocus
McKesson’s (NYSE:MCK) Q2 CY2026 Sales Top Estimates - finance.yahoo.com
McKesson reports Q1 fiscal 2027: Revenues $105.4B, Adjusted EPS $9.93, raises full-year adjusted EPS guide - TradingView
Mckesson Corp Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):